Chrome Extension
WeChat Mini Program
Use on ChatGLM
VIPCreated with Sketch.
Research Interests

Papers共 646 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Corrigendum to “familial Chylomicronemia Syndrome and Treatments to Target Hepatic APOC3 Mrna” [atherosclerosis (2025) 403 119114]
Eliot A Brinton, Robert H Eckel,Daniel Gaudet, Christie M Ballantyne, Brenda F Baker,Henry N Ginsberg, Joseph L Witztum
Atherosclerosis (2025): 119210-119210
Cited0Views0WOSBibtex
0
0
Beyond LDL: Targeting ANGPTL3 to Reduce Residual Cardiovascular Risk
Dirk J. Blom,Daniel Gaudet
Journal of the American College of Cardiologyno. 19 (2025): 1836-1838
Cited0Views0WOSBibtex
0
0
Effect of Targeting ApoC-III with Plozasiran on Lipoprotein Particle Size and Number in Hypertriglyceridemia
Christie M. Ballantyne,Daniel Gaudet,Robert S. Rosenson,Robert A. Hegele, Rong Zhou, Stacey Melquist, Jennifer Hellawell,Nicholas J. Leeper
Journal of the American College of Cardiologyno. 19 (2025): 1839-1854
Cited0Views0WOSBibtex
0
0
An Overview of Persistent Chylomicronemia: Much More Than Meets the Eye
Miriam Larouche,Gerald F Watts,Christie Ballantyne,Daniel Gaudet
Current opinion in endocrinology, diabetes, and obesityno. 2 (2025): 75-88
Cited0Views0WOSBibtex
0
0
EFFECT OF PLOZASIRAN TARGETING APOC3 ON LIPOPROTEIN PARTICLE NUMBER AND SIZE MEASURED BY NMR IN PATIENTS WITH HYPERTRIGLYCERIDEMIA (HTG)
Christie M. Ballantyne,Daniel Gaudet,Robert S. Rosenson, Robert Hegele, James Otvos, Ran Fu, Stacey Melquist, Jennifer L. Hellawell, Nicholas James Leeper
Journal of the American College of Cardiologyno. 12 (2025): 318
Cited0Views0Bibtex
0
0
Load More
Author Statistics

#Papers: 646

#Citation: 31908

H-Index: 80

G-Index: 171

Sociability: 8

Diversity: 4

Activity: 86

  • 合作者
  • 学生
  • 导师
No result temporarily, you can search similar Scholar with the same research interest
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn